Newgenivf Group Ltd (NIVF) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Newgenivf Group Ltd (NIVF) stock forecast summary
Our AI ranks Newgenivf Group Ltd outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Its market capitalization is not available, so no size classification is given.
A per-ticker accuracy statistic for NIVF is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, NIVF included.
Follow NIVF freeNIVF price chart and AI forecast
How NIVF ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Newgenivf Group Ltd (NIVF) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Misc Health & Allied Services, NEC peers listed below that report each metric.
Financial Health
| Metric | NIVF | Rank |
|---|---|---|
| D/E Ratio | 0.25x | 7/9 |
| Financial Leverage | 1.23x | 7/9 |
| Interest Coverage | -17.4x | 10/12 |
Balance Sheet Highlights (USD millions)
| Total Liabilities | $7M |
NIVF quarterly financials and insider trading
Newgenivf Group Ltd (NIVF) industry peers
Companies classified under the same SEC industry code as Newgenivf Group Ltd (Services-Misc Health & Allied Services, NEC): 13 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| NIVF Newgenivf Group Ltd | ▼ | N/A |
| DVA Davita Inc. | ▶ | $11.62B |
| FMS Fresenius Medical Care Ag | ▼ | $5.89B |
| SHC Sotera Health Co | ▼ | $5.20B |
| PGNY Progyny, Inc. | ▶ | $2.10B |
| AGL Agilon Health, Inc. | ▶ | $1.44B |
| VMD Viemed Healthcare, Inc. | ▲ | $366M |
| PARK Park Dental Partners, Inc. | ▲ | $96M |
| MRAI Marpai, Inc. | ▲ | $87M |
| CCEL Cryo Cell International Inc | ▲ | $36M |
| PFHO Pacific Health Care Organization Inc | ▲ | $12M |
| MGRX Mangoceuticals, Inc. | ▶ | $8M |
| BRTX Biorestorative Therapies, Inc. | ▶ | N/A |
Where NIVF sits on the market map
Newgenivf Group Ltd (NIVF) stock news
Loading...
Newgenivf Group Ltd (NIVF) stock forecast FAQ
What is the Newgenivf Group Ltd (NIVF) stock forecast?
Our AI ranks Newgenivf Group Ltd outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Newgenivf Group Ltd stock predictions?
A per-ticker accuracy statistic for NIVF is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Newgenivf Group Ltd forecasts updated?
Newgenivf Group Ltd forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Newgenivf Group Ltd's industry peers?
13 issuers in our coverage, NIVF included, share the SEC industry code Services-Misc Health & Allied Services, NEC. The largest are: Davita Inc. (DVA), Fresenius Medical Care Ag (FMS), Sotera Health Co (SHC), Progyny, Inc. (PGNY), Agilon Health, Inc. (AGL), Viemed Healthcare, Inc. (VMD).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.